| Ytd | -54.35% | |
| 1y | -73.84% |
| Open | 2.55 | Prev Close | 2.36 | Low | 2.42 | High | 2.61 | Mkt Cap | 2.63M |
| Vol | 352.29K | Avg Vol | 5.78M | EPS | -25.44 | P/E | -0.09 | Forward P/E | -0.62 |
| Beta | 2.84 | Short Ratio | 1.77 | Inst. Own | 13.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 3.74 | 200-d Avg | 5.45 | 1yr Est | 1.50 |
CODX News
SALT LAKE CITY, July 16, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the C
Invited by the Stop TB Partnership and the Global Fund to participate as a manufacturer partner Work
More than 1,400 patients enrolled across 9 clinical sites; analytical performance testing included 2
Co-Diagnostics completed clinical and analytical studies for its PCR Flu A/B & RSV test and plan
Expansion coincides with Co-Dx webinar for prospective mosquito abatement district customers in hono
Longstanding distribution partner to support future deployment of Co-Dx™ PCR Pro ® and expanding men
https://www.state.gov/releases/office-of-the-spokesperson/2026/06/ebola-response-update-june-5-2026/
Dual-assay strategy designed to support outbreak response and surveillance efforts in affected regio
A structural shift is underway in the biodefense landscape. The declaration of a Public Health Emerg
Joint development strategy has been developed to address international deployment requirements if cu
Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, COD
SALT LAKE CITY, May 19, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx", or the "C
Recent pathogens illustrate need for improved situational awareness capabilities, such as those prov
Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call Transcript
Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion Executi
Lease execution highlights transition from approval to development and advances localized manufactur
SALT LAKE CITY, April 30, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the
MTB test on Co-Dx PCR platform* to be presented at roundtable with Stop TB Partnership, U.S. Departm
Company to engage with global customers and distributors while expanding international commercial re
Trade mission itinerary of business, government, and industry briefings across Switzerland and Germa
Co-Diagnostics, Inc. (CODX) Q4 2025 Earnings Call Transcript
Advancing Global Commercialization Strategy Through CoSara and CoMira Joint Ventures Progressing Cli
The near-term commencement of clinical studies is expected to align with recent WHO tuberculosis rec
Co-Diagnostics (CODX) stock falls over 50% as they announced a $7 million offering and Saudi joint v
